Encompass Health Financials - Benzinga

Encompass Health Corp

EHCNYSE

Trade with Public

Trade with Public

$122.09

0.560.46%

Últ. Act.: Oct 28, 7:54 PM

Panorámica general Noticias Previsión de beneficios Eventos Precios objetivoFinanzasSentimiento Propiedad Dividendos Comparar Opciones Informe de acciones

© 2026 Benzinga | All Rights Reserved

Encompass Health Financials

Encompass Health (EHC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 Est; Raises FY2026 Sales Guidance from $6.410B-$6.490B to $6.450B-$6.500B vs $6.460B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $6.02-$6.25 to $6.23-$6.37 vs $6.11 analyst estimate. Raises FY2026 sales outlook from $6.410 billion-$6.490 billion to $6.450 billion-$6.500 billion vs

Benzinga Newsdesk

PRO
Encompass Health Q3 Adj. EPS $1.52 Beats $1.36 Estimate, Sales $1.609B Beat $1.601B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.52 per share which beat the analyst consensus estimate of $1.36 by 11.76 percent. This is a 23.58 percent increase over earnings of $1.23 per share from the

Benzinga Newsdesk

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.375B-$6.470B to $6.410B-$6.490B vs $6.421B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.89-$6.11 to $6.02-$6.25 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.375 billion-$6.470 billion to $6.410 billion-$6.490 billion vs

Benzinga Newsdesk

PRO
Encompass Health Q2 Adj. EPS $1.55 Beats $1.48 Estimate, Sales $1.597B Beat $1.571B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.55 per share which beat the analyst consensus estimate of $1.48 by 4.73 percent. This is a 10.71 percent increase over earnings of $1.40 per share from the

Benzinga Newsdesk

PRO
Encompass Health Raises FY2026 Adj EPS Guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 Est; Raises FY2026 Sales Guidance from $6.365B-$6.465B to $6.375B-$6.470B vs $6.423B Est

Encompass Health (NYSE:EHC) raises FY2026 Adj EPS guidance from $5.81-$6.10 to $5.89-$6.11 vs $6.00 analyst estimate. Raises FY2026 sales outlook from $6.365 billion-$6.465 billion to $6.375 billion-$6.470 billion vs

Benzinga Newsdesk

PRO
Encompass Health Q1 Adj. EPS $1.60 Beats $1.50 Estimate, Sales $1.586B Beat $1.569B Estimate

Encompass Health (NYSE:EHC) reported quarterly earnings of $1.60 per share which beat the analyst consensus estimate of $1.50 by 6.67 percent. This is a 16.79 percent increase over earnings of $1.37 per share from the

Benzinga Newsdesk